[go: up one dir, main page]

AU2003243058A1 - Methods for using the cd163 pathway for modulating an immune response - Google Patents

Methods for using the cd163 pathway for modulating an immune response

Info

Publication number
AU2003243058A1
AU2003243058A1 AU2003243058A AU2003243058A AU2003243058A1 AU 2003243058 A1 AU2003243058 A1 AU 2003243058A1 AU 2003243058 A AU2003243058 A AU 2003243058A AU 2003243058 A AU2003243058 A AU 2003243058A AU 2003243058 A1 AU2003243058 A1 AU 2003243058A1
Authority
AU
Australia
Prior art keywords
pathway
modulating
methods
immune response
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003243058A
Other versions
AU2003243058A8 (en
Inventor
Louis Boon
Petrus Johannes Simons
David Speijer
Ruprecht Jules Joost Van Neerven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOCEROS BV
Macrozyme BV
Original Assignee
BIOCEROS I O BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02077071A external-priority patent/EP1367393A1/en
Application filed by BIOCEROS I O BV filed Critical BIOCEROS I O BV
Publication of AU2003243058A8 publication Critical patent/AU2003243058A8/en
Publication of AU2003243058A1 publication Critical patent/AU2003243058A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596Molecules with a "CD"-designation not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003243058A 2002-05-27 2003-05-27 Methods for using the cd163 pathway for modulating an immune response Abandoned AU2003243058A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38368902P 2002-05-27 2002-05-27
EP02077071.5 2002-05-27
EP02077071A EP1367393A1 (en) 2002-05-27 2002-05-27 Methods for using the CD 163 pathway for modulating an immune response
US60/383,689 2002-05-27
PCT/NL2003/000395 WO2003100419A1 (en) 2002-05-27 2003-05-27 Methods for using the cd163 pathway for modulating an immune response

Publications (2)

Publication Number Publication Date
AU2003243058A8 AU2003243058A8 (en) 2003-12-12
AU2003243058A1 true AU2003243058A1 (en) 2003-12-12

Family

ID=29585706

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003243058A Abandoned AU2003243058A1 (en) 2002-05-27 2003-05-27 Methods for using the cd163 pathway for modulating an immune response

Country Status (2)

Country Link
AU (1) AU2003243058A1 (en)
WO (1) WO2003100419A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
WO2004100995A1 (en) * 2003-05-15 2004-11-25 Hemosol Lp Targeted delivery of anti-viral compounds through hemoglobin bioconjugation
MXPA06012216A (en) * 2004-04-23 2007-01-17 Pharmacia & Upjohn Co Llc Cellular permissivity factor for viruses, and uses thereof.
CA2628703C (en) 2005-11-30 2019-10-29 Abbott Laboratories Anti-a.beta. globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
EP1976877B2 (en) 2005-11-30 2016-10-05 AbbVie Inc. Monoclonal antibodies against amyloid beta protein and uses thereof
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2124952A2 (en) 2007-02-27 2009-12-02 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
GB0917054D0 (en) * 2009-09-29 2009-11-11 Cytoguide As Agents, uses and methods
GB0917044D0 (en) * 2009-09-29 2009-11-18 Cytoguide As Agents, uses and methods
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
MX358739B (en) 2010-08-14 2018-09-03 Abbvie Inc Star Amyloid-beta binding proteins.
US11986536B2 (en) 2019-03-23 2024-05-21 Ablevia Biotech Gmbh Compound for the sequestration of undesirable antibodies in a patient
CA3147103A1 (en) * 2019-07-19 2021-01-28 Oncoresponse, Inc. Immunomodulatory antibodies and methods of use thereof
CA3150343A1 (en) * 2019-09-09 2021-03-18 Hakon Hakonarson Compositions and methods for treatment of disorders associated with clec16a dysfunction or loss
EP4216990A1 (en) * 2020-09-23 2023-08-02 Ablevia biotech GmbH Compound for the sequestration of undesirable antibodies in a patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60140069D1 (en) * 2000-10-16 2009-11-12 Cytoguide Aps FUNCTION OF A HAPTOGLOBIN HEMOGLOBIN RECEPTOR AND APPLICATION THEREFOR

Also Published As

Publication number Publication date
AU2003243058A8 (en) 2003-12-12
WO2003100419A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
AU2003221662A1 (en) Method for operating an appliance that uses the method
AU2003249333A1 (en) Device interaction
AU2003263867A1 (en) Free fall simulator
AU2003245293A1 (en) Improved flight simulator
AU2003244499A1 (en) Support for multiple login methods.
AU2003223405A1 (en) Technique for distributing sotware background
AU2003243058A1 (en) Methods for using the cd163 pathway for modulating an immune response
AU2003220381A1 (en) Polarimeter
AU2003206210A1 (en) Educational block set
AU2003263849A1 (en) Gace spacer
AU2002242175A1 (en) Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a
AU2003278965A1 (en) Mechanism for implementing server-side pluglets
AU2003280450A1 (en) Projector
AU2003282335A1 (en) Firearm simulation device
AU2003244147A1 (en) Device for connecting two members
AU2003264722A1 (en) Methods
AU2003295702A1 (en) Signature simulator
AU2003282073A1 (en) Tight control device
AU2003284514A1 (en) Disc device
AU2003206743A1 (en) Cooking system
AUPS338802A0 (en) Simulator
AU2003259908A1 (en) Antenna-coupled microbolometer
AU2003218992A1 (en) Set-top-box
AU2003236589A1 (en) Simulator
AUPS282102A0 (en) Refinery

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 5, PAGE(S) 1100 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME BIOCEROS B.V. I.O., APPLICATION NO. 2003243058, UNDER INID (71) CORRECT THE NAME TO READ BIOCEROS B.V.; MACROZYME B.V.